Psoriatic Arthritis (PsA) 

Clinical Research Study

               Privacy Policy | Terms of Use

              Privacy Policy | Terms of Use

Not satisfied with your current Psoratic Arthritis treatment?  

Local doctors are recruiting participants to enroll in a two period clinical research study on an investigational drug for subjects with active moderate to severe psoriatic arthritis and have inadequate response to non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs). 

If you or a loved one are over 18 years old, have joints that are swollen and hurting, plaque psoriasis symptoms, and other non-biologic drugs have not worked adequately, you may qualify for this clinical study. 

You may qualify for this clinical study if you: 

  • Are 18 years old or older
  • Have been diagnosed with Psoriatic Arthritis (PsA) with symptoms for at least 6 months
  • Have a diagnosis of active plaque psoriasis or documented history of plaque psoriasis 
  • Have inadequate response to previous or current treatment with at least 1 non-biologic DMARD at maximally tolerated dose (MTX, SSZ, LEF, apremilast, bucillamine, cyclosporine, or iguratimod)

Study-related care and medication will be provided at no cost to qualified participants. Qualified participants may be compensated for travel.

To see if you might qualify to participate in this study, complete the form and survey below. 

Name *
Name
Phone *
Phone
Are you 18 or older? *
Have you been diagnosed with Psoriatic Arthritis with symptoms for at least 6 months? *
Have you been diagnosed with Plaque Psoriasis? *
Have you had inadequate response to previous or current non-biolic DMARD? *
If yes to inadequate response to non-biologic, which non-biologic DMARD treatment have you received? *